Terumo Aortic Receives Prestigious King’s Award for Innovation

Terumo Aortic today announced that it has received the prestigious King’s Award for Enterprise in the Innovation category for its innovative bespoke solutions for the treatment of complex aortic disease using a combination of surgical and endovascular technologies.

The award particularly recognises the innovation behind the Thoracoflo™ and Custom Thoraflex™ Hybrid devices, which exemplifies Terumo Aortic’s commitment to advancing aortic care through hybrid approaches. This is the company’s second King’s Award for Enterprise, having previously been the proud recipient of one King’s Award and eight Queen’s Awards.

The innovation lies in expanding their industry-leading custom solutions programme (subject to local regulatory approval) to include hybrid aortic technologies – innovative custom-made devices that combine open surgery and minimally invasive endovascular repair techniques into one tailored solution. This approach enables clinicians to treat complex aortic diseases, such as thoracoabdominal aortic aneurysms and complex aortic dissections, with tailored hybrid solutions.

Commenting on this success, Erik Pomp, Executive VP & Chief Operating Officer of Terumo Aortic, said: “We are honoured to have received this highly prestigious award which recognises our ongoing commitment to advancing aortic care. By continuously evolving our product portfolio, embracing hybrid approaches, and working in close collaboration with specialist clinicians, we are enabling improved patient outcomes. This innovation addresses the growing need for more adaptable, comprehensive solutions in the treatment of complex aortic pathology.”

The King’s Awards for Enterprise represent the highest honour for businesses and individuals in the United Kingdom and recognise outstanding achievements by UK businesses in the fields of innovation, international trade and sustainable development.